Kiersten Stead

Kiersten Stead is a highly experienced individual currently serving as a Board Member in various companies such as Mycoworks, Creyon Bio, Novome Biotechnologies, Elo Life Systems, Stemson Therapeutics, Sabanto, X-37, and DCVC Bio where Kiersten holds the position of Managing Partner. Kiersten also serves as a board member at Keystone Symposia on Molecular & Cellular Biology. Kiersten holds an MBA with a specialization in Finance, a Ph.D. in Molecular Biology and Genetics, and a B.Sc. in Cellular, Molecular and Microbial Biology from the University of Alberta and University of Calgary.